Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
Background: Dimethyl fumarate (DMF) is an oral systemic agent approved for the treatment of moderate-to-severe psoriasis vulgaris. It has a favourable tolerability profile, but it is associated with a high incidence of mild and reversible adverse events. The aim of the article is to describe a clini...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
BioExcel Publishing Ltd,
2021-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|